SHAILYNSEShaily Engineering Plastics Limited· Consumer DurablesHighPositive
Announced Wed, 25 Feb, 2026 · 15:55 IST

Shaily Engineering Plastics Limited has informed the Exchange about Bagging/Receiving of orders/contracts

Order Above 5pct RevenueBusiness Updates View source PDFExplain this filing

SHAILY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.4%Reaction day
₹1941.50
prior close
₹2028.50
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.3%+2.2% vs market
Plastic Products - Consumer peers, median of 7sector-0.1%+2.6% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.6 pts more than its Plastic Products - Consumer peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
-1.7
15m
-1.3
30m
-1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.4+0.3+2.2-0.1+2.6
Next day
+0.9-0.8+1.7+2.1-1.2
2d
+0.9-3.0+3.9-3.3+4.2
3d
-5.2-5.6+0.4-2.5-2.7
4d
-2.8-4.6+1.8-4.6+1.8
5d
-1.1-4.7+3.6-5.0+3.9
1w
-2.4-5.0+2.6-7.1+4.8
15d
+23.0-7.2+30.2-9.1+32.1
1m
+10.5-9.4+19.9-15.9+26.5
2m
+25.1+7.5+17.6-13.0+38.1
3m
+38.2+10.8+27.3-15.9+54.0
UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Consumer peers, median of 7Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shaily Engineering Plastics has signed a manufacturing and commercial supply agreement with a large domestic pharma company for the supply of pen injectors. The contract is valued at approximately Rs. 423 crores and will be executed over a period of 4 years. The customer's identity has not been disclosed due to confidentiality reasons. The transaction is a domestic deal and has no related party or promoter interest. The company specializes in plastics and has been expanding into pharma packaging and drug delivery devices.

Likely market impact

This is a sizable multi-year order that provides strong revenue visibility for the next 4 years and strengthens Shaily's positioning in the fast-growing pharma injectables segment. Positive for the stock as it signals business momentum and possible order book expansion, though customer concentration risk exists since the buyer name is undisclosed.